Chronic pancreatitis is associated with disease-specific regulatory T-cell responses
- PMID: 19931255
- DOI: 10.1053/j.gastro.2009.11.011
Chronic pancreatitis is associated with disease-specific regulatory T-cell responses
Abstract
Background & aims: Chronic pancreatitis is characterized by alternating phases of acute inflammation and quiescent disease. Involvement of T-cell responses has been suggested, but pancreatitis-specific T cells have not been described.
Methods: We characterized T-cell responses against pancreatitis, pancreatic carcinoma-associated antigens, and tetanus toxoid in the bone marrow, blood, and/or pancreatitis lesions of patients with pancreatitis, pancreatic cancer, and healthy individuals. T cells were functionally characterized by antigen-dependent secretion of interferon (IFN)-gamma, interleukin (Il)-4, and IL-10, which indicate type 1, type 2, or regulatory T-cell responses, respectively. Regulatory T cells were characterized by multicolor flow cytometry. Isolated regulatory T cells were tested for their capacity to recognize pancreatitis-associated antigens and to suppress conventional T cells in an antigen-dependent manner. T cell-derived cytokines in tissue lesions were quantified by enzyme-linked immunosorbent assay.
Results: Chronic pancreatitis patients showed similar to pancreatic cancer patients and healthy individuals type 1 T-cell responses against tetanus toxoid; however, they exhibited strong IL-10-based T-cell responses against pancreatitis-associated but not pancreatic carcinoma-associated antigens. T cells from pancreatic cancer patients responded to pancreatic cancer-associated but not pancreatitis-associated antigens with IFN-gamma secretion. Pancreatitis-specific IL-10 responses were mediated by IL-10(+)IFN-gamma(-)FoxP3(+) regulatory T cells, which were expanded in the blood, bone marrow, and pancreatitis lesions and possessed the potential to suppress the proliferation of autologous conventional T cells in an antigen-specific manner. Pancreatitis lesions, in comparison with pancreatic carcinomas, contained increased concentrations of IL-10 and reduced levels of IFN-gamma, suggesting pancreatitis-specific activity of regulatory T cells in situ.
Conclusions: Chronic pancreatitis is associated with disease-specific regulatory T-cell responses.
Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.Cancer Res. 2005 Nov 1;65(21):10079-87. doi: 10.1158/0008-5472.CAN-05-1098. Cancer Res. 2005. PMID: 16267034
-
Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.J Allergy Clin Immunol. 2007 Sep;120(3):707-13. doi: 10.1016/j.jaci.2007.06.013. Epub 2007 Aug 6. J Allergy Clin Immunol. 2007. PMID: 17681368
-
Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.Int Arch Allergy Immunol. 2009;148(3):199-210. doi: 10.1159/000161580. Epub 2008 Oct 10. Int Arch Allergy Immunol. 2009. PMID: 18849611
-
Tumefactive Inflammatory Diseases of the Pancreas.Am J Pathol. 2019 Jan;189(1):82-93. doi: 10.1016/j.ajpath.2018.05.022. Am J Pathol. 2019. PMID: 30558726 Review.
-
The role of interleukin-18 in pancreatitis and pancreatic cancer.Cytokine Growth Factor Rev. 2019 Dec;50:1-12. doi: 10.1016/j.cytogfr.2019.11.001. Epub 2019 Nov 9. Cytokine Growth Factor Rev. 2019. PMID: 31753718 Review.
Cited by
-
Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis.J Clin Invest. 2015 Feb;125(2):739-51. doi: 10.1172/JCI74894. Epub 2014 Dec 22. J Clin Invest. 2015. PMID: 25562322 Free PMC article. Clinical Trial.
-
Modeling of the immune response in the pathogenesis of solid tumors and its prognostic significance.Cell Oncol (Dordr). 2020 Aug;43(4):539-575. doi: 10.1007/s13402-020-00519-3. Epub 2020 Jun 2. Cell Oncol (Dordr). 2020. PMID: 32488850 Free PMC article. Review.
-
Novel and Experimental Therapies in Chronic Pancreatitis.Dig Dis Sci. 2017 Jul;62(7):1751-1761. doi: 10.1007/s10620-017-4604-0. Epub 2017 May 27. Dig Dis Sci. 2017. PMID: 28551708 Review.
-
Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study.Gastroenterology. 2023 Jul;165(1):173-186. doi: 10.1053/j.gastro.2023.03.236. Epub 2023 Apr 14. Gastroenterology. 2023. PMID: 37061168 Free PMC article.
-
A requisite role for induced regulatory T cells in tolerance based on expanding antigen receptor diversity.Immunity. 2011 Jul 22;35(1):109-22. doi: 10.1016/j.immuni.2011.03.029. Epub 2011 Jun 30. Immunity. 2011. PMID: 21723159 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical